목적: Improving the diagnosis and treatment of middle ear otomycosis caused by mold micromycetes. 방법:Clinical and mycological examination of 496 inpatients and outpatients. A study group comprised 267 patients with mycotic lesions of the upper respiratory tract and ear (108 of them otomycosis). Culture and microscopic research methods, methods for studying the biological properties of fungi were performed in 55 patients with otomycosis. 결과:In fungal infections of the middle ear mushrooms allocated all three genera the largest percentage accounted for Aspergillus 68,27,6% (<0,001), in second place were Penicillium 27,39,4% (<0,05), and less than others met Mucorales 4,54,4% cases. When considering the frequency of fungi isolated according to the localization of mycotic process in the ear, it is found that the percentage of the outer ear inoculation was 28,6%, from middle ear 39,3%, and from postoperative cavity 37,5%. In postoperative oral mycosis in 66,6 27,2% of cases were inoculated Aspergillus, in 33,427,2% - fungi of the genus Mucor. The share of Mucorales allocated in mycosis middle ear was negligible (4,54,4%). Treatment of fungal infections of the ear we conducted with the obligatory account of risk factors for the development of mycosis, mycotic lesion localization, the type of fungus pathogen susceptibility to antifungal drugs. Conservative therapy otomycosis middle ear include ozone therapy, systemic antimycotic therapy and topical therapy with antifungal drugs. 결론:Treatment of mycotic lesions of the middle ear trepanation cavity should be comprehensive, including revision of the postoperative cavity under the microscope, use of systemic antifungal drugs and ozone therapy in pre- and postoperative period, tympanoplastic second stage in the presence of negative mycological findings.